Cochrane · systematic review · CD009336

Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage

Oladapo, OT, Blum, J, Abalos, E, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 14.3%Very low 6 · 85.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration versus usual (or standard) care for prevention of postpartum haemorrhage

Population: women in the third stage of labour
7 questions
OutcomeEffectEvidenceStatus / GRADE
Severe postpartum haemorrhage
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
no estimate extracted1 study · 299 participantsUngraded
Serious maternal morbidity
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
no estimate extracted1 study · 299 participantsVery low
Downgraded: imprecision, indirectness
Maternal death
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
no estimate extracted1 study · 299 participantsVery low
Downgraded: imprecision, indirectness
Blood transfusion
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
no estimate extracted1 study · 299 participantsVery low
Downgraded: imprecision, indirectness
Women not using/receiving misoprostol at birth
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
RR 0.5 [0.13, 1.95]1 study · 299 participantsVery low
Downgraded: imprecision, indirectness
Inappropriate use (or misuse) of misoprostol
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
RR 4.97 [0.24, 102.59]1 study · 299 participantsVery low
Downgraded: imprecision, indirectness
Maternal transfer or referral to a health facility
Advance misoprostol distribution/provision to pregnant women for postpartum self‐administration vs usual (or standard) care
RR 0.66 [0.11, 3.91]1 study · 299 participantsVery low
Downgraded: imprecision, indirectness